from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2949c/-

LFCtreatmentdescriptionclass of inhibitor

0.026

Amikacinug/mL Amikacintranslation

0.047

Cap5-10ug/mL Capreomycintranslation

-0.522

Rox10-50 ug/mL Roxithromycintranslation

0.392

SM2-5 ug/mL Streptomycintranslation

-0.815

Tet5-10 ug/mL Tetracyclinetranslation

0.430

Rif0.2-5ug/mL Rifampicintranscription

1.051

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.878

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.821

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.540

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.992

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.178

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.354

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.169

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.178

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.566

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.342

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.629

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.137

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.331

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.745

KCN5-20 ug/mL Potassium cyaniderespiration

-0.760

NaN30.2-2 mM Sodium aziderespiration

1.032

Nigericin50 uM Nigericinrespiration

-0.496

TRC10-150 ug/mL Triclosanrespiration

-0.900

TRZ10-25 ug/mL Thioridazinerespiration

-0.693

Valinomycin0.5-10 uM Valinomycinrespiration

0.516

ZnSO42 mM ZnSO4respiration

-0.018

menadione6-10 ug/mL Menadionerespiration

0.592

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.971

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.544

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.455

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.279

NRP_1Non-replicating persistence stage 1dosRassociated

1.055

Amp0.2mg/mL AmpicillincellWall

0.783

Cephalexin20-100 ug/mL CephalexincellWall

1.623

Cerulenin0.32-5 ug/mL CerulenincellWall

0.840

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.078

EMB10-20 ug/mL EthambutolcellWall

0.569

Eta12-40 ug/mL EthionamidecellWall

1.072

INH0.2-0.4 ug/mL IsoniazidcellWall

0.358

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.518

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.732

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.230

BZA0.12 mg/mL BenzamidearomaticAmides

-0.577

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.576

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.053

H2O24 mM hydrogen peroxideDNAdamaging

1.183

Levo10 ug/mL LevofloxacinDNAdamaging

0.680

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.335

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.564

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.022

UVUV-irradiationDNAdamaging

-0.270

ARP41-4 ug/mL Antitubercular compound ARP4?

0.377

Antimycin12.5-50 ug/mL Antimycin A?

0.619

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.263

PA_110-50 ug/mL Antitubercular compound PA-1?

0.316

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.099

PA8240.2-2 ug/mL PA-824?

-0.933

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.535

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.070

Verapamil50 uM Verapamil?

0.239

mercaptoethanol2 mM 2-Mercaptoethanol?

0.680

methoxatin10-20 ug/mL Methoxatin?